Medipool Nigeria Limited has inaugurated its nine-member Board of Directors. The Board, chaired by Dr. Oluwaseun Abiola, was inaugurated in Abuja on 14 October 2026 and assumes oversight of the organisation because it strikes from institution into its subsequent section of growth.
Approved by the Federal Executive Council as a public-private partnership, Medipool aggregates the demand of Nigeria’s public well being system for medicines and different healthcare commodities. Its goals are to decrease prices, enhance provide reliability, guarantee high quality and catalyse native manufacturing of prescription drugs.
The Board contains, amongst others, Dr. Oluwaseun Abiola, Founder and Chairman; Ms. Kafayat Babalola, Executive Director and Chief Executive Officer; Pharm. Cornel Eneyi Akpandara, Executive Director and Chief Pharmaceutical Officer; Mr. Obinna Ukachukwu and Ms. Lolade Awogbade, Non-Executive Directors; and Dr. Abdu Mukhtar, Mr. Martins Olajide and Prince Henry Erimodafe, Independent Directors. Ms. Hadiza Bako is Acting Company Secretary.
Speaking on the inauguration, Dr. Abiola mentioned: “Medipool was authorized by the Federal Executive Council to do a particular job: combination the demand of Nigeria’s fragmented well being system in order that it buys higher, and transfer medicines reliably to the services that want them. An organisation with a mandate of that sort have to be held to account, and that’s what this Board is for. We will put in place the governance and controls that the Federal Government, our state companions, growth companions and the Nigerian public are entitled to anticipate, and we are going to maintain administration to the usual the mannequin was constructed to fulfill: higher worth for the Nigerian healthcare system’’.
